DGAP-News: Vara Research GmbH: QIAGEN Q3 2017 Consensus Estimates
01.11.2017 (www.4investors.de) -
DGAP-News: Vara Research GmbH / Schlagwort(e): Sonstiges
Vara Research GmbH: QIAGEN Q3 2017 Consensus Estimates
01.11.2017 / 10:56
Für den Inhalt der Mitteilung ist der Emittent verantwortlich.
The calculated consensus for QIAGEN is based on the estimates of 18 major banks consulted by Vara Research.
All consensus numbers are quoted in $ millions.
Consensus estimates (average) Q3 2017 Full Year 2017
Adjusted net sales 362.3 1417.0
Growth rate at CER in % 7.1 6.8
Adjusted operating income 95.5 366.1
Adjusted tax rate in % 17.7 17.6
Adjusted diluted EPS ($/share)(1) 0.32 1.25
Please note that the consensus is also available on the QIAGEN corporate website:
CER = Constant exchange rate
(1) Adjusted results are non-GAAP financial measures that QIAGEN believes
should be considered in addition to the reported results prepared in
accordance with generally accepted accounting principles, but should not be
considered a substitute. QIAGEN believes certain items - such as those
listed above - should be excluded from adjusted results when they are
outside the ongoing core operations, vary significantly from period to
period, or affect the comparability of results with its competitors and its
own prior periods. Includes non-GAAP sales related to the bioinformatics
This document has been issued by Vara Research GmbH for information purposes only and is not intended to
constitute investment advice. It is based on estimates and forecasts of various analysts regarding revenues, earnings
and business developments of the relevant company. Such estimates and forecasts cannot be independently verified
by reason of the subjective character. Vara Research GmbH gives no guarantee, representation or warranty and is not
responsible or liable as to its accuracy and completeness.
01.11.2017 Veröffentlichung einer Corporate News/Finanznachricht, übermittelt durch DGAP - ein Service der EQS Group AG. Für den Inhalt der Mitteilung ist der Emittent / Herausgeber verantwortlich.Die DGAP Distributionsservices umfassen gesetzliche Meldepflichten, Corporate News/Finanznachrichten und Pressemitteilungen. Medienarchiv unter http://www.dgap.de
Probiodrug: Drei entscheidende Jahre im Kampf gegen Alzheimer
Gigaset: „Werden bald eine ganz neue Art von Kommunikation erleben“